Updated hourlyHourly refreshWed, Sep 23, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare
The American Medical Association (AMA) and Atalan announced a new research collaboration focused on advancing understanding of the factors that influence physician retention across U.S. health systems. - - The two organizations have agreed to combine resources and launch the PROGRESS Study (Physician Retention, Optimization, and Growth: Real-world Evidence and Sentiment Synthesis), a multi-site research initiative aimed at helping health systems better understand the conditions that sup... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=360558
Sep 16 · 13:15·WebWire
Healthcare
- - • Expands specialised infrastructure for temperature-sensitive healthcare products - • Further strengthens Kuehne+Nagel's global network of more than 270 HealthChain-certified locations - • Builds on recent healthcare logistics developments in Frankfurt, including the Frankfurt-Atlanta Cool Corridor - - - Kuehne+Nagel has opened a 3,505 sqm healthcare logistics centre at Frankfurt Airport, expanding specialised capacity for the handling of temperature-sensitive pharma and healthca... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=360556
Sep 16 · 13:09·WebWire
Healthcare
(PR-inside.com) 18 health plans earn top 5-star rating. WASHINGTON, D.C. / ACCESS Newswire / September 16, 2026 / The National Committee for Quality Assurance (NCQA) announced its 2026 Health Plan Ratings - an annual report that helps healthcare consumers and regulators assess the quality and effectiveness of health plans. Ratings evaluate commercial, Medicare Advantage (MA) and Medicaid health plans based on measures of clinical quality, patient experience and outcomes. The 2026 ratings are based primarily on 2025 performance data, with select MA measures reflecting 2024 results due to federal reporting schedules. Health plans are rated on a scale of 0-5 stars, with 5 ..
Sep 16 · 13:05·PR-Inside
Finance · Healthcare
(PR-inside.com) Learn how TransCode Therapeutics is advancing RNA therapeutics, cancer vaccines, and immuno-oncology programs designed to address advanced and metastatic cancers Management to discuss TTX-MC138, the ongoing Phase 2a colorectal cancer trial, tumor-targeted RNA delivery, and multiple upcoming clinical catalysts ORLANDO, FL / ACCESS Newswire / September 16, 2026 / RedChip Companies will host an investor webinar today, September 16, 2026, at 4:15 p.m. ET with TransCode Therapeutics, Inc. (NASDAQ:RNAZ). The webinar is free to attend and open to all. The exclusive event will feature Philippe P. Calais Ph.D., Chairman and CEO; Zdravka Medarova, Ph.D., Co-founder and Chief Scientific Officer; and Tom Fitzgerald, Chief ..
Sep 16 · 13:00·PR-Inside
Healthcare
ARLINGTON, Va., Sept. 16, 2026 /PRNewswire/ -- More than eight in ten companies anticipate significant business risk due to a new Medicare program called Competitive Bidding. This program will dramatically limit contracts for certain categories of essential medical products used every day...
Sep 16 · 12:54·PR Newswire
Finance · Healthcare
(PR-inside.com) New CEO-led video series provides investors with straight talk, just the facts, with no B.S. or corporate spin Real answers to what investors need to know about enVVeno and why they need to know it Watch the inaugural episode here IRVINE, CA / ACCESS Newswire / September 16, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company"), today announced the launch of "WTF Rob Berman" a new video series that provides the information that investors need to know, in straight talk, with no corporate spin. Hosted by enVVeno Medical CEO Rob Berman, the WTF series is designed to go beyond the usual ..
Sep 16 · 12:50·PR-Inside
AI · SaaS
New platform unites healthcare signals, AI-powered engagement led by Grace, and a proprietary network of curated, bundled-payment care partners to help employers, TPAs and healthcare innovators lower costs and close care gaps before they become claims. DALLAS, Sept. 16, 2026 /PRNewswire/...
Sep 16 · 12:50·PR Newswire
Finance · Healthcare
NeOnc NASDAQ: NTHI) executives have made approximately $629,000 in insider buys since announcing its Phase 2a results on August 12.
Sep 16 · 12:46·GlobeNewswire
Finance · Healthcare
BDBV-Specific Construct Developed Using GeoVax Proprietary Rapid Cloning Technology and Builds on Established Filovirus Vaccine Experience GEO-MVA (Mpox/Smallpox Vaccine) Targeted for Phase 3 Initiation Remains Company Priority ATLANTA, GA - September 16, 2026 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing vaccines and immunotherapies against infectious diseases and solid tumor cancers, today announced the development of a vaccine construct targeting Bundibugyo virus (BDBV), the cause of the ongoing Bundibugyo virus disease outbreak in the Democratic Republic of Congo. The BDBV construct was generated using GeoVax’s proprietary MVA-based rapid-cloning technology, designed to enable rapid insertion or replacement of vaccine antigens in response to em
Sep 16 · 12:37·NewMediaWire
SaaS · Healthcare
(PR-inside.com) Nitches Inc. (OTCID:NICH) opens its scoring platform, its FDA-registered U.S. manufacturing pathway, and a direct line to national mass-market retail buyers to creators, athletes, influencers, and everyday founders with a supplement idea in gummy, capsule, or tablet form. Submissions are open now at NutraVeri.com. MIAMI, FL / ACCESS Newswire / September 16, 2026 / For decades, the question of what goes on the supplement shelf has been answered in corporate conference rooms. Today, that changes. Nitches Inc. (OTCID:NICH) announced that NutraVeri, its supplement-readiness and commercialization platform, has opened a national search for the next generation of founder-created supplements-and, for the first time, ..
Sep 16 · 12:30·PR-Inside
Finance · Healthcare
Experienced medical device quality and regulatory leader brings 13 years of experience supporting quality systems, regulatory compliance, audits and product development Experienced medical device quality and regulatory leader brings 13 years of experience supporting quality systems, regulatory compliance, audits and product development
Sep 16 · 12:30·GlobeNewswire
SaaS · Healthcare
Nitches Inc. (OTCID:NICH) opens its scoring platform, its FDA-registered U.S. manufacturing pathway, and a direct line to national mass-market retail buyers to creators, athletes, influencers, and everyday founders with a supplement idea in gummy, capsule, or tablet form. Submissions are open now at NutraVeri.com.
Sep 16 · 12:30·Newswire.com